0
Obstructive Lung Diseases: Fellow Case Report Poster - Obstructive Lung Disease |

Aggressively Targeting the Inflammatory Pathway in SLE-PAH Improved Hemodynamics and Allowed for Titration Off Prostacyclin

Said Chaaban, MD; George Samuel, MD; Rana Awdish, MD
Author and Funding Information

Henry Ford Health System, Detroit, MI


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):906A. doi:10.1016/j.chest.2016.08.1006
Text Size: A A A
Published online

Extract

SESSION TITLE: Fellow Case Report Poster - Obstructive Lung Disease

SESSION TYPE: Affiliate Case Report Poster

PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM

INTRODUCTION: Pulmonary Arterial hypertension (PAH) is a progressive disease confers a poor prognosis, often leading to right ventricular failure and death. Prostacyclin infusion is Class IA recommendation for the treatment of patients with NYHA FC III and IV symptoms. Despite its pivotal role in management, patients often find it onerous as administration is complex, requiring central venous access, and small errors in administration can be life-threatening. Transition off of parenteral therapy to oral or inhaled agents is often a patient goal, but can be difficult to achieve.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543